Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.
View Top Employees from Arecor Therapeutics plc| Website | http://www.arecor.com |
| Revenue | $6 million |
| Funding | $8 million |
| Employees | 45 (45 on RocketReach) |
| Founded | 2007 |
| Phone | +44 1223 426060 |
| Fax | +44 1223 423411 |
| Technologies |
JavaScript,
HTML,
Twitter
+13 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biopharma, Heat Stable Vaccines, Business Services, Biotechnology, High Concentration Antibodies, Health Care, Combination Biologic Products, Science and Engineering, Improved protein stability, Education, Live Attenuated Viruses (Lavs), Pharmaceutical, Rational Formulation Design |
| Web Rank | 12 Million |
| Keywords | Arecor |
| Competitors | Bioquark Inc., Leukocare AG, LifeCycle Pharma Inc, OxThera, QuatRx Pharmaceuticals Company |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Arecor Therapeutics plc employee's phone or email?
Arecor Therapeutics plc Questions
The Arecor Therapeutics plc annual revenue was $6 million in 2024.
Susan Lowther is the CFO of Arecor Therapeutics plc.
45 people are employed at Arecor Therapeutics plc.
The NAICS codes for Arecor Therapeutics plc are [32541, 32, 325, 3254].
The SIC codes for Arecor Therapeutics plc are [28, 283].
Top Arecor Therapeutics plc Employees
-
2
-
ViewJan Jezek
Chief Scientific Officer at Arecor Therapeutics plc
Cambridge, Cambridgeshire, United Kingdom1 -
View
David Gerring
Vice President Of Development at Arecor Therapeutics plc
Cambridge, Cambridgeshire, United Kingdom11 -
41
-
2
Related Companies
